Association between cytochrome P450 enzymes metabolism and cardiovascular protection
Ni, L.; Wang, D-wen.
Zhonghua Xin Xue Guan Bing Za Zhi 38(4): 377-379
2010
ISSN/ISBN: 0253-3758 PMID: 20654090 Document Number: 643829
Document emailed within 1 workday
Related Documents
Rivera-Mancía, S.; Jiménez-Osorio, Aélica.Saraí.; Medina-Campos, O.Noel.; Colín-Ramírez, Eísa.; Vallejo, M.; Alcántara-Gaspar, A.; Cartas-Rosado, Rúl.; Vargas-Barrón, Jús.; Pedraza-Chaverri, Jé. 2018: Activity of Antioxidant Enzymes and Their Association with Lipid Profile in Mexican People without Cardiovascular Disease: An Analysis of Interactions International journal of environmental research and public health 15(12)Thomas, P.E.; Lu, A.Y.; West, S.B.; Ryan, D.; Miwa, G.T.; Levin, W. 1977: Accessibility of cytochrome P450 in microsomal membranes: inhibition of metabolism by antibodies to cytochrome P450 Molecular Pharmacology 13(5): 819-831
Zhao, M.X.; Kan, F.F.; Fang, F.S.; Tian, H. 2016: A cohort study on the association between fasting plasma glucose level over 5.3 mmol/L and risks of abnormal glucose metabolism and cardiovascular diseases in the elderly Zhonghua Nei Ke Za Zhi 55(5): 340-344
Koudriakova, T.; Iatsimirskaia, E.; Utkin, I.; Gangl, E.; Vouros, P.; Storozhuk, E.; Orza, D.; Marinina, J.; Gerber, N. 1998: Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(6): 552-561
Mlinarić-Galinović, G.; Zagar, Z. 1977: Procedure for the detection cytochrome-oxidase enzymes in bacteria Lijecnicki Vjesnik 99(8): 471-476
Sattler, M.; Guengerich, F.P.; Yun, C.H.; Christians, U.; Sewing, K.F. 1992: Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(5): 753-761
Baede van Dijk, P.A.; de Graeff, P.A.; Lekkerkerker, J.F. 1999: Role of cytochrome P450 enzymes in pharmaceutical preparations Nederlands Tijdschrift Voor Geneeskunde 143(52): 2607-2611
Vereczkey, L.; Jemnitz, K.; Monostory, K. 1997: Human liver cytochrome P-450 and conjugating enzymes. Hungarian data Acta Physiologica Hungarica 85(2): 149-152
Shimada, T.; Guengerich, F.P. 1990: Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes Cancer Research 50(7): 2036-2043
Khisamov, G.Z.; Morozova, G.Z. 1987: The role of enzymes of amino acid and lipid metabolism in Leptospira metabolism Vestnik Akademii Meditsinskikh Nauk SSSR 7: 84-90
Yamazaki, H.; Guo, Z.; Persmark, M.; Mimura, M.; Inoue, K.; Guengerich, F.P.; Shimada, T. 1994: Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes Molecular Pharmacology 46(3): 568-577
Williams, D.E.; Reed, R.L.; Kedzierski, B.; Dannan, G.A.; Guengerich, F.P.; Buhler, D.R. 1989: Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(4): 387-392
Hoensch, H.; Malchow, H.; Schmid, R. 1976: Cytochrome P-450 and drug decomposing enzymes in the rat small intestinal mucosa: localization and control factors Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 945-948
Kim, C.H.; King, T.E. 1991: Effect of pyridoxal phosphate on the formation of cytochrome c1-c and cytochrome c-cytochrome oxidase complexes Biochemistry International 24(2): 255-262
Abdel-Razzak, Z.; Loyer, P.; Fautrel, A.; Gautier, J.C.; Corcos, L.; Turlin, B.; Beaune, P.; Guillouzo, A. 1993: Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture Molecular Pharmacology 44(4): 707-715
Shimada, T.; Tsumura, F.; Yamazaki, H. 1999: Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(11): 1274-1280
Iwasaki, M.; Iwama, M.; Miyata, N.; Iitoi, Y.; Kanke, Y. 1994: Effects of vitamin E deficiency on hepatic microsomal cytochrome P450 and phase II enzymes in male and female rats International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 64(2): 109-112
Relling, M.V.; Evans, W.E.; Fonné-Pfister, R.; Meyer, U.A. 1989: Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomes Cancer Research 49(1): 68-71
Roomi, M.W. 1997: Association between hyperlipidemia and hepatic cytochrome P-450 in guinea pigs Research Communications in Molecular Pathology and Pharmacology 97(2): 139-150
Diletti, R.; Krychtiuk, K.; Pöss, J.; Rubini-Gimenez, M.; Tejedor, A.Viana. 2014: The 'Young Acute Cardiovascular Care Association group' of the Acute Cardiovascular Care Association European Heart Journal 35(27): 1770-1771